Research Techniques Made Simple: Use of Imaging Mass Cytometry for Dermatological Research and Clinical Applications by Veenstra, Jesse et al.
Henry Ford Health System 
Henry Ford Health System Scholarly Commons 
Dermatology Articles Dermatology 
4-1-2021 
Research Techniques Made Simple: Use of Imaging Mass 





David M. Ozog 
See next page for additional authors 
Follow this and additional works at: https://scholarlycommons.henryford.com/dermatology_articles 
Authors 
Jesse Veenstra, Peter Dimitrion, Yi Yao, Li Zhou, David M. Ozog, and Qing-Sheng Mi 
Research Techniques Made Simple: Use of Imaging
Mass Cytometry for Dermatological Research
and Clinical Applications
Jesse Veenstra1,2,3, Peter Dimitrion2,3,4, Yi Yao1,2,3, Li Zhou1,2,3,4, David Ozog1 and
Qing-Sheng Mi1,2,3,4,5
Traditional immunohistochemistry (IHC) is inherently limited by its ability to analyze only several markers
within a histological tissue section at a given time, which hinders in-depth characterization and phenotyping of
tissues. Imaging mass cytometry (IMC), which combines IHC using metal-labeled antibodies with laser ablation
and detection using mass cytometry by time-of-flight, overcomes this limitation with the capability to simul-
taneously analyze up to 40 protein markers to generate high-dimensional images from a single tissue section.
IMC analysis preserves tissue architecture and spatial cellular relationships that would otherwise be lost or
significantly altered in applications requiring tissue dissociation, such as flow cytometry or single-cell RNA
sequencing. Resulting high-dimensional histological images permit spatially conserved analysis to identify
unique cell populations, cellular interactions and avoidances, and insight into activation and behavioral status
based on tissue location. IMC can be performed on both frozen and formalin-fixed paraffin-embedded tissue,
allowing for previously banked samples to be analyzed and correlated with known clinical outcomes.
Expectedly, IMC will change the landscape of investigative pathology, particularly when used in coordination
with multiomic platforms to combine transcriptomic and proteomic data at a single-cell resolution. Here, we
aim to highlight the potential utility of IMC within dermatologic research and clinical applications.
Journal of Investigative Dermatology (2021) 141, 705e712; doi:10.1016/j.jid.2020.12.008
INTRODUCTION
Tissue architecture plays an essential role in both physio-
logical and pathological processes necessary to understand
normal homeostasis and the development of disease. Not
surprisingly, histopathology remains among the most critical
and widely used tools for dermatologic researchers and
clinicians to investigate and diagnose cutaneous disease,
where numerous structural elements and cellular types
interact with one another. Despite the utility of routine his-
topathology, it has limited capability to define molecular
features important to investigators to fully understand the
tissue microenvironment. Although traditional immunohis-
tochemistry (IHC) or immunofluorescence (IF) can quantify
molecular markers to supplement H&E staining, it is inher-
ently limited by its ability to analyze only several markers
from a single section at a time, which hinders in-depth
characterization and phenotyping of tissues. These limita-
tions preclude IHC from simultaneously phenotyping mul-
tiple cell types, cellular interactions, and cellular states in
parallel with tissue markers. Although techniques for high-
dimensional histological imaging exist, such as serial IF,
their utility is limited by the precision of target detection with
fluorophores prone to spectral overlap and the time-
intensive nature, making them less clinically useful
(Gerdes et al., 2013). Therefore, a need exists for a highly
multiplexed histology platform that is compatible with
routinely collected formalin-fixed paraffin-embedded (FFPE)
tissues, enables quantification of many markers simulta-
neously, provides single-cell resolution and high-throughput
analysis capability, allows for fully customizable panels, and
can be readily analyzed.
Recent advances using cytometry by time-of-flight (CyTOF)
has led to the advent of imaging mass cytometry (IMC), which
combines IHC using metal-labeled antibodies with laser
ablation and detection by mass spectrometry to generate
multiplexed images. IMC overcomes the limitations of tradi-
tional IHC and IF with the current capacity to analyze up to
40 targets from a single scan with 135 available detection
channels, significantly augmenting the ability to evaluate
complex cellular systems and processes. IMC can also be
performed on FFPE or frozen tissues, allowing for previously
banked samples with known clinical outcomes to be
analyzed. Although IMC remains a relatively new technology
and has not been widely used in dermatology thus far, its use
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should rapidly increase given myriad advantages over tissue
analysis methods (Table 1) and the ability to integrate within
multiomics analysis pipelines. In this review, we describe the
potential applications of IMC for dermatologic research and
practice.
IMC WORKFLOW
Before tissue imaging, the design phase is critical to ensure
that appropriate metal-tagged antibodies are selected and
optimized to tissues of interest with both positive and nega-
tive controls (Figure 1). It is recommended to optimize non-
validated IMC antibodies with IF before metal conjugation,
which serves as a surrogate for IMC detection performance.
Antibodies to a wide array of targets, including extracellular,
intracellular, and signal transduction pathways, have been
successfully employed for IMC. The technical aspects of IMC
and CyTOF are further reviewed in the complementary
Research Techniques Made Simple article by Naderi-Azad
et al. and prior similar articles, respectively (Doan et al.,
2015; Matos et al., 2017). Once IMC is complete, raw im-
ages can be rendered to high-dimensional images with each
marker pseudocolored per investigator preference. Single-cell
segmentation from images is possible using a combination of
different open-source software, such as Ilastik and CellPro-
filer. The resulting single-cell data is conducive to the same
analysis pipelines used to analyze CyTOF data as previously
reviewed (Matos et al., 2017), with the added dimensions of
cell shape, size, and localization. Publicly available algo-
rithms can integrate both cytometric and spatial data to
enable a more detailed analysis of IMC data (Schapiro et al.,
2017). Further integration with other data sets from relevant
subjects and specimens enables a multiomics approach for
improved sample classification and subsequent clinical cor-
relation, which is further discussed hereafter.
PRACTICAL USES IN DERMATOLOGIC RESEARCH
With the advent of single-cell omics, researchers have begun
to appreciate the importance of individual cellular subsets
and states in the pathogenesis of numerous diseases. IMC can
capture this heterogeneity at single-cell resolution while
preserving the spatial orientation of different cell types, sub-
classes, and activation states (e.g., inflammatory or anti-
inflammatory). The flexibility in assessing the localization of
specific cell types and states lies in the development of a
question-driven IMC antibody panel. Questions may be
broad and exploratory, such as, “Is there a spatially regulated
cellular or tissue biomarker for a certain disease state or
stage?” or “What is the immune cell landscape in lesional
versus perilesional skin or epidermis versus dermis?” Indeed,
one recent publication utilized IMC to assess the infiltration
and spatial localization of various immune cell subsets within
lesions from patients with hidradenitis suppurativa (HS)
(Gudjonsson et al., 2020). The investigators used an IMC
panel of 12 markers targeting different immune subsets, such
as plasma cells, B cells, monocytes and macrophages, CD8 T
cells, and neutrophils, which found substantially increased
leukocyte infiltration in HS lesional tissue relative to normal
skin. In contrast, questions can also be more targeted, such as,
“What is the ratio of activated and exhausted CD8 T cells
infiltrating tumor versus stroma?” or “What is the landscape of
T-cell phenotypes in a cutaneous malignancy?” Defining re-
gions of interest based on tissue architecture or lesional or
tumorestroma boundaries can further provide meaningful
biological context to spatial data.
As previously noted, cell segmentation can be performed
on IMC images to permit single-cell phenotypic-based
SUMMARY POINTS
 Imaging mass cytometry (IMC) of tissues, which
utilizes mass cytometry by time-of-flight (CyTOF)
technology, enables highly multiplexed
histological imaging with single-cell resolution
using up to 40 markers from a single scan.
 Resulting histological images permit spatially
conserved single-cell analysis to identify and
phenotype unique cell populations and
associated cellular interactions and provide
insight into activation and behavioral status and
signal transduction cascades.
 Previously banked formalin-fixed paraffin-
embedded or frozen tissues can be used and
correlated to known clinical outcomes.
 Tissue microarrays from multiple samples can be
constructed on a single slide to enable high-
throughput analysis.
Advantages
 In a single scan, IMC enables quantification of up
to 40 markers, with 135 available detection
channels.
 There is minimal to no spectral overlap or
background signal with the use of metal-tagged
antibodies in contrast to fluorophores used in
immunofluorescence.
 Antibody panels are fully customizable with
metal conjugation reagents.
 Multiple regions of interest can be selected for
scanning from a single slide, which can be
visualized in real time and remotely monitored.
Limitations
 Initial CyTOF equipment cost is substantial.
 There is limited availability of institutions offering
IMC Core services to outside investigators.
 Metal-labeled antibodies are more costly than
fluorophore-conjugated antibodies.
 The entire slide is not imaged, only the region of
interest.
 Region of interest size is limited based on the
time required to perform ablation.
 Imaged tissue is laser ablated and cannot be
reused for subsequent applications.
 High-dimensional imaging requires advanced
analysis tools to utilize all data to the greatest
extent.
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clustering to define cell clusters and populations within the
sample, which can then be linked back to the original his-
tological image to gain a deeper understanding of where
cellular subsets are localized; this process has been coined
round-trip analysis (Schapiro et al., 2017). In other words,
instead of identifying specific cellular markers (i.e., CD3,
CD4, Histone 3) in tissue sections, round-trip analysis con-
denses these markers and allows the visualization of a cellular
phenotype (i.e., memory, proliferating, activated, and
exhausted T-cell phenotypes).
It is well known that immune cells utilize cell surface
contacts to mediate cellular crosstalk and coordinate func-
tion. From localizing cell types, one can also determine
cellecell interactions or groups of cells interacting from IMC
data, so-called neighborhood analysis. This analysis relies on
the number and frequency of interactions and avoidances
Figure 1. IMC Workflow. (a) After experimental planning and selection of appropriate samples and markers, staining of tissues of interest and appropriate
controls are optimized. (b) FFPE or frozen tissues are prepared on glass slides and can be in the form of custom-built tissue microarrays composed of numerous
specimens to aid in high-throughput analysis. (c) Slides are stained with metal-tagged antibodies and then IMC is performed by laser ablation in conjunction with
CyTOF. (d) Multidimensional images are generated and pseudocolored per user specifications for visualization. (e) Preliminary cell phenotyping is possible based
on targets analyzed, and single-cell segmentation is performed from raw image files to enable downstream (f) single-cell analysis with phenotype-based
clustering algorithms (i.e., Phenograph, FlowSOM). (g) If available, IMC data can be incorporated with other relevant data sets, such as spatially defined
transcriptomics, for a multiomics approach. (h) Each sample can be classified based on the composition of cell types and cellular interactions (e.g., single-cell
pathology subgroups). (i) Newly classified samples can be correlated with known clinical outcomes from imaged tissues. CyTOF, cytometry by time-of-flight;
FFPE, formalin-fixed paraffin-embedded; IMC, imaging mass cytometry.
Table 1. Differences between IMC and IF
Imaging Attributes IMC IF
Highly multiplexed imaging
40 markers
Yes Only with serial IFa
Resolution Subcellular (1 mm) Subcellular (dependent on microscope)
Simultaneous target readout 40 1-5
Scanning automatization with real-time visualization Yes No
Background signal and spectral overlap Minimal to none Yes (further increases with number of cycles)
Tissue ablated Yes No
Area imaged Regions of interest Objective field of view
Throughput w2 hrs/mm2 Hours per cycle
Marker coloring User-selected (pseudocoloration) Fluorophore dependent
Equipment required CyTOF mass cytometer Confocal or super-resolution microscopes
CyTOF, cytometry by time-of-flight; IF, immunofluorescence; IMC, imaging mass cytometry.
aSerial Immunofluorescence is an IF technique with the capability to generate highly multiplexed images using multiple cycles of staining and fluorophore
bleaching (Gerdes et al., 2013).
www.jidonline.org 707
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between defined populations of cells. Such analyses can help
generate cellecell interaction networks that go awry in dis-
ease to identify key pathways and potential targets for
immunotherapy or define disease-specific cellular commu-
nities with prognostic value. Additionally, neighborhood
analysis can determine whether certain cell types have a
predilection or aversion for clustering in a tissue, which may
indicate a disease-driving process. Defining interacting
communities of cells and neighborhoods adds another level
of depth to IMC analysis. This opens a new avenue of
investigation into defining the etiology and pathogenesis of
skin disease by expanding the scope of questions from a cell
type to a community type.
Recently, a multiomics investigation of human cutaneous
squamous cell carcinoma (cSCC) utilizing multiplexed ion
beam imaging (MIBI) with a panel of 38 markers to perform
high-dimensional imaging, spatial transcriptomics, and
single-cell RNA sequencing identified a previously unchar-
acterized population of tumor-specific keratinocytes (TSKs)
in tumor, but not matched normal, skin (Ji et al., 2020). MIBI
is similar to IMC with the use of metal-labeled antibodies
but, instead of a laser, uses an ion beam to raster over the
tissue to generate secondary ions for detection by a sector
field mass spectrometer (Figure 2c) (Bodenmiller, 2016);
serial immunofluorescence and IMC methods are illustrated
respectively in Figure 2a and b. Specimen imaging with MIBI
(Figure 3a) uncovered prominent inter- and intratumor
microenvironment heterogeneity across cSCC clinical
specimens (Figure 3b and c). The integration of data across
all platforms revealed that TSKs serve as the principal hub for
intercellular communication within cSCC that influences
tumor progression, immunosuppression, and heterogeneity.
Despite considerable tumor heterogeneity, a more in-depth
analysis of spatially resolved immune infiltrates revealed a
strong correlation between CD8 T cells, CD4 T cells, regu-
latory T cells (Tregs), and macrophages (Figure 3d). Fibro-
blasts, macrophages, and Tregs were predominantly at the
tumorestroma border, whereas CD8 T cells and neutro-
phils were largely excluded from the tumor, indicating that
Treg and macrophage positioning may limit effector
lymphocyte access to the tumor (Figure 3e and f). B cells,
which may mediate either antitumor or suppressive
Figure 2. Immunofluorescence versus
mass cytometry for highly
multiplexed imaging. (a) Serial
immunofluorescence imaging uses
cycles of tissue staining and imaging
with one or a few fluorescently labeled
antibodies, quenching of the
fluorescence by fluorochrome
destruction or antibody removal, and
restaining with additional antibodies.
(b) In CyTOF imaging mass cytometry,
a tissue is stained with dozens of
metal-labeled antibodies
simultaneously. A high-resolution
laser ablation system is then used to
transfer the tissue spot-by-spot into the
CyTOF mass cytometer to determine
metal isotope content and, therefore,
epitope expression. (c) In multiplexed
ion beam imaging, the tissue is stained
with 10 metal-labeled antibodies
simultaneously. A primary ion beam is
used to raster over the tissue to
generate secondary ions, among them
the metal isotopes that were bound to
the antibodies. A sector field mass
spectrometer is then used to determine
the metal isotope content and,
therefore, epitope expression in each
rastered area. CyTOF, cytometry by
time-of-flight; ICP-TOF MS,
inductively coupled plasma time-of-
flight mass spectrometer; MS, mass
spectrometer. Reprinted from
(Bodenmiller, 2016) with permission
from Elsevier.
Journal of Investigative Dermatology (2021), Volume 141708
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immunity, were the only cell type found to infiltrate the tu-
mor compartment preferentially.
Ji et al. (2020) also demonstrate the integration of high-
dimensional imaging with other single-cell technologies,
such as single-cell transcriptomics and spatial tran-
scriptomics. Although IMC requires targets to be defined a
priori, single-cell transcriptomics and spatial transcriptomics
have no such requirement, which allows for remarkable de
novo discovery of pathogenic cell states, phenotypes, be-
haviors, and communities. Notably, single-cell transcriptomic
technologies, which simultaneously classify cells based on
epitope expression and transcriptomic profiles, integrate
seamlessly with IMC because the user can match IMC targets
with the epitope index (Stoeckius et al., 2017). This allows
deeper characterization of IMC-defined cellular subclusters
and states and spatially regulated gene expression networks
and together provides more confidence in newly discovered
cell populations, as transcriptionally defined subsets are not
always readily distinguished at the protein level. An integra-
tive omics approach that includes IMC provides an unprec-
edented breadth and depth of analysis that evaluates tissue
architecture and spatial relationships between cellular subsets
and communities, which will undoubtedly be valuable to
defining the etiology of skin diseases and improving our un-
derstanding of cutaneous biology.
CLINICAL UTILITY OF IMC
Many complex cellular phenotypes and cellular relationships
can be identified within the spatial context of intact tissues
using highly multiplexed imaging via IMC, which enables
superior histopathological classification of clinical samples
and potential for improved prognostication (Giesen et al.,
2014). The feasibility and power of this concept were
recently demonstrated in breast cancer, where a panel of
known and putative prognostic biomarkers was used to
characterize novel single-cell pathology (SCP) subgroups
Figure 3. Spatial architecture of lymphocyte subsets in cSCC. (A) Select MIBI FOVs for patient samples with expression of highlighted features. (b) Heatmap of
feature expression across cell types identified by MIBI. (c) Top, bar plots of proportion of nontumor cell types across all FOVs. Bottom, bar plots of total
numbers of nontumor cells identified in each FOV. (d) Correlation heatmap of nontumor cell types across all FOVs. (e) Nontumor cells flagged by location
relative to tumor and stromal compartments. (f) Heatmap of relative abundance of cell types in each compartment. Values represent proportion of total nontumor
cells in compartment contributed by each cell type. cSCC, cutaneous squamous cell carcinoma; dsDNA, double-stranded DNA; FOV, field of view; KC,
keratinocyte; MIBI, multiplexed ion beam imaging; Treg, regulatory T cell. Adapted from (Ji et al., 2020) under a CC-BY license.
www.jidonline.org 709
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based on cellular composition, cellular interactions, and tis-
sue organization among a large cohort of banked FFPE breast
cancer specimens with known clinical outcomes (Jackson
et al., 2020). The newly identified SCP subgroups were
found to better predict and segregate clinical outcomes when
compared with current standard clinical grading criteria using
hormone receptor and HER-2 status (Figure 4aeh). They
found that almost no solitary marker was independently
associated with clinical outcomes, whereas the composition
of cellular communities that comprised SCP subgroups did
(Figure 4i). Similar methodology will likely be able to be
utilized for other diseases, such as melanoma, to better
classify and correlate tissue pathology with patient survival,
disease progression, and likelihood of response to targeted
therapies or immune checkpoint blockade.
It bears mentioning that although other single-omics plat-
forms, such as single-cell RNA sequencing and suspension-
based CyTOF, require fresh tissue for analysis, IMC can uti-
lize previously banked FFPE tissue with known clinical out-
comes. This is especially helpful in dermatology given the
sheer number of cutaneous biopsies from a multitude of
different conditions that are available. This facilitates
Figure 4. SCP subgroups have distinct clinical outcomes. (aeh) KaplaneMeier curves of overall survival for each patient group (n ¼ 278 patients in total) on the
basis of (a) clinical subtype, (b) clinical grade, (cef) SCP subgroup, or (g, h) stromal environment. *P < 0.05 compared with all other samples, #P < 0.05
compared with similar subgroups, †P < 0.05 compared with other HRþHER2 patients (log-rank test). (i) Relative hazard ratios and 95% confidence intervals of
disease-specific overall survival for densities of tumor communities and microenvironment communities and clinical categories (molecular subtype and grade)
estimated using a Cox proportional hazards model (n ¼ 266 patients, reference group HRþHER2e grade 3 for molecular subtypes and grades, n ¼ 15 were
excluded as only communities with fewer than 10 cells were identified in these patients). SCP, single-cell pathology. Reprinted from (Jackson et al., 2020) with
permission from Springer Nature.
Journal of Investigative Dermatology (2021), Volume 141710
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investigators and clinicians alike to pose a research question,
select relevant tissues, perform analysis, and obtain mean-
ingful results that can be correlated to patient-specific out-
comes within a relatively brief time frame in comparison to
lengthy prospective studies that would otherwise be required.
Implementing IMC in this fashion will likely aid in expanding
precision medicine throughout dermatology.
CONCLUSION
Although, to date, there have not been many studies uti-
lizing IMC in investigative dermatology, its use will un-
doubtedly expand given its powerful capability to provide
highly multiplexed spatially resolved imaging with single-
cell resolution of banked clinical specimens. Furthermore,
recent work has shown how IMC integrates with tran-
scriptomics to enable unparalleled multiomics analysis
that has begun to characterize previously unknown cell
populations and interactions to shed light on disease
pathogenesis. This approach facilitates the ability to cap-
ture the full potential of multiplexed imaging to investi-
gate biologic complexities at both the tissue and cellular
level. Thus, it is clear that spatially preserved, single-cell
analysis via IMC is an exciting new histological imaging
platform that can characterize tissue, cellular, and cellular
community heterogeneity in a previously unfeasible
manner, which will prove invaluable to deeply investigate
cutaneous pathology. Resulting data have the potential to
improve on predictive value for disease diagnosis, prog-
nosis, or relapse and better inform patient-specific clinical
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MULTIPLE CHOICE QUESTIONS





D. Cytometry by time-of-flight (CyTOF)
2. Which of the following is the primary
consideration when planning an IMC
experiment?
A. Availability of fresh tissue
B. Appropriate antibodies are selected and
optimized to tissues of interest with both
positive and negative controls
C. What commercial IMC kits are available
D. Selection of your top 25 markers of interest
3. Which of the following is an advantage of IMC
over immunofluorescence techniques?
A. Highly multiplexed imaging with a single
scan
B. Minimal to no background signal and spectral
overlap
C. User-defined marker coloring
(pseudocoloration)
D. All of the above
4. Which of the following cannot be analyzed by
IMC from human skin samples?
A. Localization of cellular markers (i.e.,
CD4, IFNg) in different layers of the
epidermis
B. Whole transcriptomes from keratinocyte
subsets within a melanoma section
C. Perifollicular immune cell populations
from patients with moderate to severe
psoriasis
D. Extracellular matrix proteins in the dermis
from a perilesional tissue sample from a
patient with lichen planus
5. Which of the following is a potential application
of IMC in the clinic?
A. Determination of tumor heterogeneity and
immune infiltrates within preserved tissue
architecture
B. Identification of novel single-cell pathology
subgroups to better predict clinical
outcomes
C. Characterization of single-cell interactions
and relationships
D. Integration with transcriptomic data
E. All of the above
www.jidonline.org 711
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DETAILED ANSWERS
1. What is the detection method for imaging mass cytometry
(IMC)?
CORRECT ANSWER: D. Cytometry by time-of-flight (CyTOF)
IMC combines metal-labeled antibodies with laser abla-
tion and detection using mass CyTOF. The other choices are
not used as a method of detection in IMC.
2. Which of the following is the primary consideration when
planning an IMC experiment?
CORRECT ANSWER: B. Appropriate antibodies are selected
and optimized to tissues of interest with both positive and
negative controls
Before tissue staining and imaging, the design phase is
critical to ensure that appropriate metal-tagged antibodies are
selected and optimized to tissues of interest with both positive
and negative controls. Fresh tissue is not required for IMC;
both formalin-fixed paraffin-embedded and frozen tissues can
be used. Users can create fully customized antibody panels
performing metal conjugation to selected antibodies. IMC
currently has the capacity to detect up to 40 markers in a
single scan.
3. Which of the following is an advantage of IMC over
immunofluorescence techniques?
CORRECT ANSWER: D. All of the above
All of the choices listed are advantages of IMC over
immunofluorescence.
4. Which of the following cannot be analyzed by IMC from
human skin samples?
CORRECT ANSWER: B. Whole transcriptomes from kerati-
nocyte subsets within a melanoma section
All of the options except for B assess proteins from different
skin samples. Although antibodies do exist to analyze some
noncoding RNAs and studies have been able to measure
mRNA using oligonucleotide antibodies, IMC cannot be used
to efficiently acquire the entire transcriptome from any kind of
cells. This is where the integration with other omics tech-
nologies complement IMC.
5. Which of the following is a potential application of IMC
in the clinic?
CORRECT ANSWER: E. All of the above
All of the choices listed are potential applications of IMC.
www.jidonline.org 712.e1
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